Cytarabine 100 mg / DAUNOrubicin 44 mg Liposome Injection
RxNorm 1942743
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1942743 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: cytarabine 100 mg / DAUNOrubicin 44 mg Liposome Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
Semantic Clinical Drug (SCD):
Cytarabine liposome 100 mg / daunorubicin liposomal 44 mg Injection
(Atom ID: 12350403)
Synonym (SY):
Ara-C liposome 100 mg / Daunorubicin Liposomal 44 mg Injection
(Atom ID: 9268858)
Tall Man Lettering Synonym (TMSY):
Ara-C liposome 100 mg / DAUNOrubicin Liposomal 44 mg Injection
(Atom ID: 9268871)
Prescribable Name (PSN):
Cytarabine 100 mg / DAUNOrubicin 44 mg Liposome Injection
(Atom ID: 9268449)
Synonym (SY):
Cytarabine 100 mg / daunorubicin 44 mg Liposome Injection
(Atom ID: 9268448)
Tall Man Lettering Synonym (TMSY):
Cytarabine 100 mg / DAUNOrubicin 44 mg Liposome Injection
(Atom ID: 9268869)
Tall Man Lettering Synonym (TMSY):
Cytarabine liposome 100 mg / DAUNOrubicin liposomal 44 mg Injection
(Atom ID: 12385615)
Designated preferred name (PT):
Cytarabine liposome 100 mg and daunorubicin liposome 44 mg powder for solution for infusion vial
(Atom ID: 12943991)
Full form of descriptor (FN):
Product containing precisely cytarabine liposome 100 mg and daunorubicin liposome 44 mg/1 vial powder for conventional release solution for infusion (clinical drug)
(Atom ID: 12944152)
Patient Education
Daunorubicin and Cytarabine Lipid Complex Injection
Daunorubicin and cytarabine lipid complex is used to treat certain types of acute myeloid leukemia (AML; a type of cancer of the white blood cells) in adults and children 1 year of age and older. Daunorubicin is in a class of medications called anthracyclines. Cytarabine is in a class of medications called antimetabolites. Daunorubicin and cytarabine lipid complex slows or stops the growth of cancer cells in your body.
[Learn More]
Cancer Chemotherapy
Normally, your cells grow and die in a controlled way. Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects.
You may have a lot of side effects, some, or none at all. It depends on the type and amount of chemotherapy you get and how your body reacts. Some common side effects are fatigue, nausea, vomiting, pain, and hair loss. There are ways to prevent or control some side effects. Talk with your health care provider about how to manage them. Healthy cells usually recover after chemotherapy is over, so most side effects gradually go away.
Your treatment plan will depend on the cancer type, the chemotherapy drugs used, the treatment goal, and how your body responds. Chemotherapy may be given alone or with other treatments. You may get treatment every day, every week, or every month. You may have breaks between treatments so that your body has a chance to build new healthy cells. You might take the drugs by mouth, in a shot, as a cream, or intravenously (by IV).
NIH: National Cancer Institute
[Learn More]
* Please review the disclaimer below.
